Form 8-K - Current report:
SEC Accession No. 0001564590-21-003281
Filing Date
2021-01-29
Accepted
2021-01-29 11:34:27
Documents
5
Period of Report
2021-01-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 1Q 2021 SPA rkda-8k_20210125.htm 8-K 38927
2 EX-4.1 rkda-ex41_15.htm EX-4.1 138556
3 EX-4.2 rkda-ex42_14.htm EX-4.2 134998
4 EX-10.1 rkda-ex101_13.htm EX-10.1 286757
5 EX-10.2 rkda-ex102_12.htm EX-10.2 161756
  Complete submission text file 0001564590-21-003281.txt   762182
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 21569497
SIC: 0100 Agricultural Production-Crops